Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group

Background Hodgkin lymphoma is highly curable but associated with significant late effects. Reduction of total treatment would be anticipated to reduce late effects. This aim of this study was to demonstrate that a reduction in treatment was possible without compromising survival outcomes. Methods P...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2012-12, Vol.59 (7), p.1259-1265
Hauptverfasser:	Tebbi, Cameron K., Mendenhall, Nancy P., London, Wendy B., Williams, Jonathan L., Hutchison, Robert E., FitzGerald, Thomas J., de Alarcón, Pedro A., Schwartz, Cindy, Chauvenet, Allen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bleomycin - administration & dosage Child children and adolescents Disease-Free Survival Dose Fractionation Doxorubicin - administration & dosage Etoposide - administration & dosage Female Hodgkin Disease - drug therapy Hodgkin Disease - mortality Hodgkin Disease - pathology Hodgkin Disease - radiotherapy Hodgkin lymphoma Humans Male Razoxane - administration & dosage Remission Induction response-dependent Survival Rate Vincristine - administration & dosage Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!